Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

医学 共病 内科学 危险系数 移植 造血细胞 造血干细胞移植 比例危险模型 置信区间 造血 干细胞 遗传学 生物
作者
Mohamed L. Sorror,Rainer Storb,Brenda M. Sandmaier,Richard T. Maziarz,Michael A. Pulsipher,Michael B. Maris,Smita Bhatia,Fabiana Ostronoff,H. Joachim Deeg,Karen L. Syrjala,Elihu H. Estey,David G. Maloney,Frederick R. Appelbaum,Paul J. Martin,Barry E. Storer
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:32 (29): 3249-3256 被引量:350
标识
DOI:10.1200/jco.2013.53.8157
摘要

Age has long been used as a major factor for assessing suitability for allogeneic hematopoietic cell transplantation (HCT). The HCT-comorbidity index (HCT-CI) was developed as a measure of health status to predict mortality risk after HCT. Whether age, comorbidities, or both should guide decision making for HCT is unknown.Data from 3,033 consecutive recipients of HLA-matched grafts from five institutions contributed to this analysis. Patients were randomly divided into a training set to develop weights for age intervals and a validation set to assess the performance of prognostic models.In the training set, patients age 20 to 39 years, 40 to 49 years, 50 to 59 years, and ≥ 60 years had hazard ratios for nonrelapse mortality (NRM) of 1.21 (P = .29), 1.48 (P = .04), 1.75 (P = .004), and 1.84 (P = .005), respectively, compared with those age younger than 20 years. Consequently, age ≥ 40 years was assigned a weight of 1 to be added to the HCT-CI to constitute a composite comorbidity/age index. In the validation set, the composite comorbidity/age score had statistically significantly higher c-statistic estimates for prediction of NRM (0.664 v 0.556; P < .001) and survival (0.682 v 0.560; P < .001) compared with age, respectively. Patients with comorbidity/age scores of 0 to 2 had comparable mortality risks regardless of conditioning regimens. Patients with scores of 3 to 4 and ≥ 5 had statistically significant higher mortality risks after high-dose versus nonmyeloablative regimens.Age is a poor prognostic factor. The proposed composite measure allows integration of both comorbidities and age into clinical decision making and comparative-effectiveness research of HCT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健应助袁翰将军采纳,获得10
刚刚
Rollei发布了新的文献求助10
刚刚
Rollei发布了新的文献求助10
刚刚
Rollei发布了新的文献求助10
刚刚
Rollei发布了新的文献求助10
1秒前
Rollei发布了新的文献求助10
1秒前
Rollei发布了新的文献求助10
1秒前
淡然靖柔完成签到,获得积分10
1秒前
清脆怜寒完成签到,获得积分10
1秒前
赖雅绿完成签到,获得积分10
2秒前
辞树完成签到,获得积分10
2秒前
ugly_20201208完成签到,获得积分10
2秒前
大意的凝云完成签到,获得积分10
3秒前
HH完成签到,获得积分10
4秒前
5秒前
7秒前
珈蓝完成签到,获得积分10
7秒前
嘟嘟请让一让完成签到,获得积分10
8秒前
莫x莫完成签到 ,获得积分10
9秒前
bubble完成签到,获得积分10
10秒前
10秒前
万能图书馆应助sl采纳,获得10
10秒前
河丫应助sl采纳,获得10
10秒前
量子星尘发布了新的文献求助10
11秒前
科研人发布了新的文献求助10
11秒前
11秒前
魏莱关注了科研通微信公众号
12秒前
dd发布了新的文献求助10
13秒前
yifan92完成签到,获得积分10
14秒前
15秒前
灵巧的孤容完成签到,获得积分10
16秒前
袁翰将军发布了新的文献求助10
16秒前
a雪橙完成签到 ,获得积分10
18秒前
超帅的碱完成签到,获得积分10
18秒前
19秒前
陈大海完成签到,获得积分20
19秒前
LaTeXer给积极行天的求助进行了留言
19秒前
白斯特完成签到,获得积分10
20秒前
科研混子完成签到,获得积分10
20秒前
听雨完成签到 ,获得积分10
20秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038446
求助须知:如何正确求助?哪些是违规求助? 3576149
关于积分的说明 11374627
捐赠科研通 3305875
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892680
科研通“疑难数据库(出版商)”最低求助积分说明 815048